The Federal Trade Commission (FTC) said on July 28 that it has launched a public inquiry into whether consumers, particularly minors, have been harmed by false or unsubstantiated claims about “gender-affirming care,” and whether such practices may violate federal law.
The launch of the public inquiry follows a July 9 FTC workshop that featured testimony from doctors, ethicists, whistleblowers, detransitioners, and parents who alleged that some providers made unsupported claims about the safety or effectiveness of the treatments and failed to disclose material risks.